SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-18-034809
Filing Date
2018-05-21
Accepted
2018-05-21 16:14:25
Documents
18
Period of Report
2018-05-21
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a18-13054_18k.htm 8-K 23137
2 EX-99.1 a18-13054_1ex99d1.htm EX-99.1 22660
3 EX-99.2 a18-13054_1ex99d2.htm EX-99.2 22004
4 GRAPHIC g130541mmi001.jpg GRAPHIC 4893
5 GRAPHIC g130541moi001.gif GRAPHIC 94957
6 GRAPHIC g130541moi002.gif GRAPHIC 115076
7 GRAPHIC g130541moi003.gif GRAPHIC 39980
8 GRAPHIC g130541moi004.gif GRAPHIC 116048
9 GRAPHIC g130541moi005.gif GRAPHIC 64492
10 GRAPHIC g130541moi006.gif GRAPHIC 65929
11 GRAPHIC g130541moi007.gif GRAPHIC 95199
12 GRAPHIC g130541moi008.gif GRAPHIC 87346
13 GRAPHIC g130541moi009.gif GRAPHIC 160398
14 GRAPHIC g130541moi010.gif GRAPHIC 69167
15 GRAPHIC g130541moi011.gif GRAPHIC 133082
16 GRAPHIC g130541moi012.gif GRAPHIC 148724
17 GRAPHIC g130541moi013.gif GRAPHIC 49195
18 GRAPHIC g130541moi014.gif GRAPHIC 51865
  Complete submission text file 0001104659-18-034809.txt   1854995
Mailing Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713
Business Address 2530 MERIDIAN PARKWAY SUITE 300 DURHAM NC 27713 919-806-4487
Dova Pharmaceuticals, Inc. (Filer) CIK: 0001685071 (see all company filings)

IRS No.: 813858961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38135 | Film No.: 18849747
SIC: 2834 Pharmaceutical Preparations